Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Adv Healthc Mater. 2014 Feb 25;3(7):1086–1096. doi: 10.1002/adhm.201300646

Figure 2. MSC tenogenic gene expression in response to scaffold anisotropy and soluble factor supplementation.

Figure 2

Expression of tenogenic genes A) SCXB and B) TNC was measured at days 7, 14, and 21 (n = 3). Scaffold anisotropy significantly improved MSC SCXB expression. While GDF supplementation did not improve SCXB expression, it is elicited significant up-regulation of TNC at day 21 in anisotropic scaffolds. *: significant difference at that time point compared to standard. ⋀: significant up-regulation compared to previous time point.